A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients

计划入组 1,052 人 · 首次发布于 2016 年 8 月 11 日

Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses

计划入组 240 人 · 首次发布于 2015 年 9 月 21 日

Establishing a Controlled Human Infection Model of Bordetella Pertussis

计划入组 79 人 · 首次发布于 2021 年 11 月 29 日

Bordetella pertussis pertactin antigen(Adacel, Boostrix, Daptacel, Pentacel, Quadracel, Vaxelis)

SMNH compounds (oral, norovirus infection) (Spring Bank Pharmaceuticals)

immunotherapy (nosocomial infections)

Spero Therapeutics

United States

Scynexis

United States

GlaxoSmithKline

United Kingdom

Roche Receives FDA Clearance for 15-Minute Point-of-Care Bordetella PCR Test

FDA Approves Fosfomycin Injection for Complicated Urinary Tract Infections

Trinity College Dublin Develops Needle-Free Nasal Vaccine That Blocks Whooping Cough Transmission